As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.
7 Analysts have issued a HCW Biologics Inc forecast:
7 Analysts have issued a HCW Biologics Inc forecast:
| Sep '25 |
+/-
%
|
||
| Revenue | 0.43 0.43 |
88%
88%
|
|
| Gross Profit | 0.09 0.09 |
92%
92%
|
|
| EBITDA | -11 -11 |
71%
71%
|
|
| EBIT (Operating Income) EBIT | -11 -11 |
70%
70%
|
|
| Net Profit | -22 -22 |
40%
40%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
HCW Biologics, Inc. operates as a holding company which engages in the research and development of immunotherapies. It focuses on cancer and aging-associated diseases. The company was founded by Hing C. Wong on April 2, 2018 and is headquartered in Miramar, FL.
| Head office | United States |
| CEO | Hing Wong |
| Employees | 36 |
| Founded | 2018 |
| Website | hcwbiologics.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


